Rapid Response 2024

The Institute is pleased to announce the re-launch of our flagship Rapid Response program, which is designed to provide seed funding to catalyze novel, high-risk, high-reward translational research for neurodegenerative disease of aging (NDAs).  

Eligible projects should:

• Be translational research that can accelerate therapeutic or tool development for NDAs, as defined by the Institute.
  • Therapeutics should address unmet needs in the prevention, treatment and/or symptomatic management of NDAs. 
  • Tools should address challenges in translational research to accelerate the development and/or clinical implementation of therapeutics for NDAs (e.g., biomarkers, drug delivery systems).  
• Have preliminary data to support the hypothesis and feasibility of the project.

Funding per project: Up to $300,000 over 18-24 months

Important dates:

• Program information session:  April 2, 2024 (register here).
• Letter of Intent deadline: April 30, 2024 (Apply here: https://westonfdn.smartsimple.ca/)
• Award announcement: November 2024

For more information about this program, including details on project and applicant eligibility, Institute definitions, program review criteria and expected project outcomes, please visit our website to access the RFA, the Program Details document and the Letter of Intent template.